IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C - Wikidata - awgldk - TriplyDB

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

http://www.wikidata.org/entity/Q27480600

about

Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis C Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus.

P2860

Q27490352-7EC11624-41D7-432F-AAD8-FD76F73F8644 Q42988195-AC1B126E-3EA6-487D-95A1-4818E5AB047A

P2860

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

http://www.wikidata.org/entity/Q27480600

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

@ast

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

@en

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

@nl

type

label

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

@ast

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

@en

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

@nl

prefLabel

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

@ast

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

@en

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

@nl

P1433

Q27480600-5AF2D1B1-2259-42A2-920C-8B2AC7947CCF

P1476

Q27480600-D11608AC-EA13-4731-BFE5-113B80F8ED27

P2093

Q27480600-0A826046-EB36-4375-9FAD-16BAE33F22A9

Q27480600-1D7F67BD-E955-4C8F-B303-6D295028F366

Q27480600-1FE4AD80-41E9-4708-9BCA-63808F7FA806

Q27480600-58E856FE-DEC8-4B9C-B73D-04B0B8887C92

Q27480600-5E6A3E31-1C1D-41DC-9A0A-11AC4EA8ABCA

Q27480600-83E7986F-0358-49CB-851C-1F29A1CF1DCA

Q27480600-9B7613D3-7E1F-4BDF-AE52-5BC2B0EEE9D5

Q27480600-A3FD699E-8356-4E99-BBA0-7D61059B97FA

Q27480600-DA56C70D-3EAC-45A5-B1C9-1AE39B058A14

Q27480600-DAE2CF29-4C64-4CD2-89ED-5C514D82CA0B

P2860

Q27480600-0F43A047-6682-496B-B617-CE4AB1F05BE8

Q27480600-10AB1D06-155D-45AC-83F8-505292431D8F

Q27480600-1C93A8E5-486F-446C-BE75-339884F1FA93

Q27480600-1E0E50C8-2AC8-4865-AF8C-484005C82799

Q27480600-1FCA5EA7-4C6A-4071-AECA-FD095957C765

Q27480600-30A03CB3-043E-48EA-B884-F8A10C0489F6

Q27480600-310292A9-C7BC-496B-B95D-4E69BFEF7507

Q27480600-35880056-1A0F-4221-AB4C-F04FE27E6583

Q27480600-44133FC9-697B-4843-AA0C-0A4F109D0B11

Q27480600-4ED21EB1-B6F9-4AE1-A903-D7D69A2215EE

P304

Q27480600-B042F1CE-2E40-46B4-A460-3607FB63DD36

P31

Q27480600-E33C7936-C778-4DC4-AF15-39C31C86506E

P356

Q27480600-7F3961EC-CFB7-49AB-A3BF-529422C4CEB9

P433

Q27480600-8D5458DB-6427-4698-B5A0-DDF36A1DF3BC

P478

Q27480600-F2332EF5-FDA8-4F1F-86B8-7B638690190B

P577

Q27480600-D7700051-458F-4B58-8CF0-7492C7EED240

P5875

Q27480600-8EFE453D-D178-47C0-B9FB-E17E9A184FDE

P698

Q27480600-C612F99A-C543-4393-B0B4-46B9BFC9A9D9

P932

Q27480600-8CBE0B3A-CF5E-450B-846A-E4BD139E301C

P356

J.1365-2249.2001.01648.X

P1433

Clinical and Experimental Immunology

P1476

IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C

@en

P2093

H Maekawa

http://www.w3.org/2001/XMLSchema#string

H Mitsui

http://www.w3.org/2001/XMLSchema#string

H Yamada

http://www.w3.org/2001/XMLSchema#string

J Green

http://www.w3.org/2001/XMLSchema#string

K Koike

http://www.w3.org/2001/XMLSchema#string

K Yasuda

http://www.w3.org/2001/XMLSchema#string

M Hirayama

http://www.w3.org/2001/XMLSchema#string

N Hashimoto

http://www.w3.org/2001/XMLSchema#string

S Iino

http://www.w3.org/2001/XMLSchema#string

S Kimura

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and organization of the hepatitis C virus genome isolated from human carriers

Immunodominant regions within the hepatitis C virus core and putative matrix proteins

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

The serology of chronic hepatitis B infection revisited.

Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C.

Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen.

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

P304

92-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2249.2001.01648.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11673819

http://www.w3.org/2001/XMLSchema#string

P698

11678904

http://www.w3.org/2001/XMLSchema#string

P932

1906173

http://www.w3.org/2001/XMLSchema#string